Cannabis Law Report

JULY 28, 2021

Validates Cepharanthine’s potential in treating various cancers with unsatisfactory treatment options. Advance to FDA IND-enabling studies to support human clinical studies. Previously the Company announced that it had secured FDA Orphan Drug Designation for cepharanthine in the treatment of esophageal cancer.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Veriheal

AUGUST 31, 2020

Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Nishtha Tripathi. Program between St.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

NOVEMBER 7, 2019

The delivery of high quality and consistent medicinal products is key to providing good treatment outcomes for patients around the world and ensuring Good Manufacturing Practice (GMP) is paramount for treatment efficacy. Cannatrek is actively working on clinical trial protocols with a dedicated focus on mental health.

Medicine 40

Medicine Patients Research and Development Clinical Trials 40

Cannabis Law Report

SEPTEMBER 3, 2019

The laws allow concentrate-based medical cannabis to be prescribed in Australia for the treatment of a variety of specific illnesses. Global Supply Chain Platform. MediPharm Labs Australia is expected to serve as part of MediPharm Labs’ global supply chain platform and a springboard to serving the Asia-Pacific region.

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45

Cannabis Law Report

DECEMBER 21, 2021

Engaging in these markets required Dalrada’s perseverance to overcome continual supply chain delays created by the pandemic that is now in its second year. Tests include on-site rapid antigen (results in under 20 minutes) and on-site RT-PCR sample collection (results in 24 hours). billion by 2030, growing at a CAGR of 8.4%

Research and Development 52

Research and Development Supply Chain Data Business 52

Cannabis Law Report

AUGUST 30, 2019

The measure has the backing of several national dispensary chains, including MedMen, Harvest Health and Recreation and Curaleaf Holdings. Dubbed the the “Smart & Safe Arizona Initiative,” supporters of the effort must collect more than 237,645 valid signatures from voters by July 2, 2020, for the measure to be on the 2020 ballot.

Banking 45

Banking Research and Development Legislation Programs 45